Oligonucleotide API Market - Global Outlook and Forecast 2023-2028

Report ID: 1365941 | Published Date: Oct 2024 | No. of Page: 75 | Base Year: 2023 | Rating: 4.2 | Webstory: Check our Web story

This report contains market size and forecasts of Oligonucleotide API in global, including the following market information:
Global Oligonucleotide API Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Oligonucleotide API Market Sales, 2017-2022, 2023-2028, (Ton)
Global top five Oligonucleotide API companies in 2021 (%)
The global Oligonucleotide API market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Antisense Oligonucleotides API Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Oligonucleotide API include Jazz Pharmaceuticals, Sarepta Therapeutics, Biogen, Dynavax Technologies, Akcea Therapeutics, Alnylam Pharmaceuticals, Nitto Denko (Avecia), Ajinomoto (GeneDesign) and RiboBio. etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Oligonucleotide API manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Oligonucleotide API Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (Ton)
Global Oligonucleotide API Market Segment Percentages, by Type, 2021 (%)
Antisense Oligonucleotides API
Small Interfering RNA (siRNA) API
MiRNA API
CpG Oligonucleotides API
Others
Global Oligonucleotide API Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (Ton)
Global Oligonucleotide API Market Segment Percentages, by Application, 2021 (%)
Contract Manufacturing Organizations (CMOs)
Pharmaceutical Companies
Global Oligonucleotide API Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (Ton)
Global Oligonucleotide API Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Oligonucleotide API revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Oligonucleotide API revenues share in global market, 2021 (%)
Key companies Oligonucleotide API sales in global market, 2017-2022 (Estimated), (Ton)
Key companies Oligonucleotide API sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Jazz Pharmaceuticals
Sarepta Therapeutics
Biogen
Dynavax Technologies
Akcea Therapeutics
Alnylam Pharmaceuticals
Nitto Denko (Avecia)
Ajinomoto (GeneDesign)
RiboBio

Frequently Asked Questions
Oligonucleotide API Market report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Oligonucleotide API Market report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Oligonucleotide API Market report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports